MRK vs VTRS
By Alex · Tickerpine
Merck & Company, Inc. vs Viatris Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | VTRS |
|---|---|---|
| Price | $132.92 | $16.10 |
| Market cap | $327.94B | $18.49B |
| P/E ratio | 106.3 | — |
| ROE | 6.96% | -2.75% |
| Profit margin | 4.77% | -2.79% |
| Revenue growth | 5.10% | 4.90% |
| Dividend yield | 2.56% | 2.98% |
| Beta | 0.21 | 0.89 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs VTRS in plain English
- MRK is the bigger company — about 17.7× the market cap of VTRS.
- MRK earns a higher return on equity (7% vs -3%).
- MRK is growing revenue faster (5% vs 5%).
- VTRS has the higher dividend yield (2.98% vs 2.56%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
VTRS return calculator
See what $1,000 in Viatris Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.